Publications

1. Lee , A, Chan , CK, Seo , EY, Park , S, Lu , WJ, Hong , WX, Kim , BYS, Jiang , W, Nag , D, Lin , S, Nguyen , P, Weissman , IL, Wu , JC, Longaker , M. Formation of de novo blood vessels by a novel multipotent vessel progenitor cell population for treatmetn of ischemic injury. Journal of Clinical Investigation.2017;
   
2. Chow , KH, Park , H, Yamamoto , K, Gallup , A, Chen , Y, Jiang , W, Kim , BYS, Steindler , D, Yun , K. GBM stemness and mesenchyma transition mechanisms Cancer Research.2017;77:(20):
   
3. Jiang , W, Chan , CK, Krishnan , S, Chen , J, Weissman , IL, Kim , BYS. Immune modulatory nanomedicine for cancer therapy. Science Immunology.2017;3:(1):
   
4. Jiang W, Yuan H, Chan CK, von Roemeling CA, Yan Z, Weissman IL, Kim BYS. Lessons from immuno-oncology: a new era for cancer nanomedicine? Nat Rev Drug Discov 2017 Jun; 16 (6):369-370 Epub 2017 Mar 17
   View PubMed
5. Yuan H, Jiang W, von Roemeling CA, Qie Y, Liu X, Chen Y, Wang Y, Wharen RE, Yun K, Bu G, Knutson KL, Kim BYS. Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy. Nat Nanotechnol 2017 May 01 [Epub ahead of print]
   View PubMed
6. Jiang W, von Roemeling CA, Chen Y, Qie Y, Chen J, Kim BYS. Designing nanomedicine for immuno-oncology Nature Biomedical Engineering.2017;01:(01):1-11.
   
7. von Roemeling C, Jiang W, Chan CK, Weissman IL, Kim BY. Breaking Down the Barriers to Precision Cancer Nanomedicine. Trends Biotechnol 2017 Feb; 35 (2):159-171 Epub 2016 Aug 01
   View PubMed
8. Jiang , W, Chan , CK, Weissman , IL, Kim , BYS, Hahn , SM. Immune Priming of the Tumor Microenvironment by Radiation Trends in Cancer.2016;2:(11):638-345.
   
9. Pizzi MA, Alejos DA, Siegel JL, Kim BY, Miller DA, Freeman WD. Cerebral Venous Thrombosis Associated with Intracranial Hemorrhage and Timing of Anticoagulation after Hemicraniectomy. J Stroke Cerebrovasc Dis 2016 Sep; 25 (9):2312-6 Epub 2016 June 16
   View PubMed
10. Jiang W, Mohamed AS, Kim BYS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 2016 Jul-Aug; 6 (4):241-7 Epub 2015 Nov 10
    View PubMed
11. Yushi Q, Li Z, Von Roemeling CA, Doeppler H, Marlow LA, Kim BY, Radisky DC, Storz P, Copland JA, Tun HW. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma. Oncotarget 2016 May 31; 7 (22):32156-71
    View PubMed
12. Qie Y, Yuan H, von Roemeling CA, Chen Y, Liu X, Shih KD, Knight JA, Tun HW, Wharen RE, Jiang W, Kim BY. Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes. Sci Rep 2016 May 19; 6:26269
    View PubMed
13. Liu J, Mao K, Jiang S, Jiang W, Chen K, Kim BY, Liu Q, Jacobs LK. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB. Oncotarget 2016 Apr 26; 7 (17):24848-59
    View PubMed
14. Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI, Beadle BM, Frank SJ, Morrison WH, El-Naggar AK, Glisson BS, Sturgis EM, Phan J. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas. Head Neck 2016 Apr; 38 Suppl 1:E1459-66 Epub 2015 Nov 11
    View PubMed
15. Liu J, Mao K, Jiang S, Jiang W, Chen K, Kim B, Liu Q, Jacobs L. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB. Oncotarget. Nov 2015.
    
16. Jiang W, Huang Y, An Y, Kim BYS. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. ACS Nano 2015 Sep 22; 9 (9):8689-96 Epub 2015 July 31
    View PubMed
17. Jiang W, Gullane P, Gentili F, Kim BYS, DeMonte F. Non-contiguous leptomeningeal metastasis of olfactory neuroblastoma. J Neurooncol.2015;
    View PubMed
18. Liu J, Jiang W, Mao K, An Y, Su F, Kim BYS, Liu Q, Jacobs LK. Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis. Breast Cancer Res Treat. 2015; 150(2):439-45.
    View PubMed
19. Kim BY, Jiang W, Beiko J, Prabhu SS, DeMonte F, Gilbert MR, Sawaya R, Aldape KD, Cahill DP, McCutcheon IE. Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing. J Neurooncol. 2014 Jun; 118(2):405-12. Epub 2014 Apr 29.
    View PubMed
20. Rutka JT, Kim B, Etame A, Diaz RJ. Nanosurgical resection of malignant brain tumors: Beyond the cutting edge. ACS nano. 2014; 8(10):9716-22.
    View PubMed
21. Kim BY, Jonasch E, McCutcheon IE. Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report. Target Oncol. 2012 Jun; 7(2):145-9. Epub 2012 Feb 29.
    View PubMed
22. Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010 Dec 16; 363(25):2434-43.
    View PubMed
23. Kim BY, Jiang W, Oreopoulos J, Yip CM, Rutka JT, Chan WC. Biodegradable quantum dot nanocomposites enable live cell labeling and imaging of cytoplasmic targets. Nano Lett. 2008 Nov; 8(11):3887-92. Epub 2008 Sep 25.
    View PubMed
24. Jiang W, Singhal A, Kim BYS, Zheng J, Rutka IT, Wang C, Chan WCW. Near-Infrared Emitting Quantum Dots for Deep Tissue, Organ and Animal Imaging Applications. Journal of the Association for Laboratory Automation. 2008; 13(1):6-12.
    
25. Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanomaterial-Based Drug Delivery: Progress and Challenges. Expert Opinion in Drug Delivery. 2007; 4:621-3.
    
26. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002 May 2; 417(6884):74-8.
    View PubMed
27. Abounader R, Ranganathan S, Kim BY, Nichols C, Laterra J. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. J Neurochem. 2001 Mar; 76(5):1497-508.
    View PubMed